loadpatents
name:-0.016468048095703
name:-0.015377044677734
name:-0.016381978988647
Reutlinger; Michael Patent Filings

Reutlinger; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reutlinger; Michael.The latest application filed is for "benzodiazepine derivatives as gaba a gamma1 pam".

Company Profile
18.14.16
  • Reutlinger; Michael - Basel CH
  • Reutlinger; Michael - Freiburg DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Triazolo-azepine derivatives
Grant 11,440,915 - Bartels , et al. September 13, 2
2022-09-13
Phenoxytriazoles
Grant 11,319,314 - Bartels , et al. May 3, 2
2022-05-03
Phenoxytriazoles
App 20210309653 - BARTELS; Bjoern ;   et al.
2021-10-07
Benzodiazepine Derivatives As Gaba A Gamma1 Pam
App 20210309664 - CECERE; Giuseppe ;   et al.
2021-10-07
Difluoroketamide derivatives as HtrA1 inhibitors
Grant 11,059,858 - Maerki , et al. July 13, 2
2021-07-13
Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
Grant 11,014,963 - Hornsperger , et al. May 25, 2
2021-05-25
Difluoroketamide derivatives as HTRA1 inhibitors
Grant 11,001,555 - Hornsperger , et al. May 11, 2
2021-05-11
Bicyclic heteroaryl derivatives
Grant 10,941,147 - Bartels , et al. March 9, 2
2021-03-09
Bridged piperidine derivatives
Grant 10,899,766 - Bartels , et al. January 26, 2
2021-01-26
Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
Grant 10,870,623 - Hornsperger , et al. December 22, 2
2020-12-22
Difluoroketamide derivatives as HtrA1 inhibitors
Grant 10,865,182 - Maerki , et al. December 15, 2
2020-12-15
Triazolo-azepine Derivatives
App 20200317681 - BARTELS; Bjoern ;   et al.
2020-10-08
Pyrimidine Derivatives
App 20200291032 - BARTELS; Bjoern ;   et al.
2020-09-17
Fused pyrimidine derivatives
Grant 10,730,881 - Bartels , et al.
2020-08-04
Fused pyrimidine derivatives
Grant 10,669,276 - Bartels , et al.
2020-06-02
Bicyclic heteroaryl derivatives
Grant 10,647,721 - Bartels , et al.
2020-05-12
Bridged Piperidine Derivatives
App 20200031831 - BARTELS; Bjoern ;   et al.
2020-01-30
Difluoroketamide derivatives
Grant 10,428,108 - Hornsperger , et al. October 1, 2
2019-10-01
Bicyclic Heteroaryl Derivatives
App 20190284191 - BARTELS; Bjoern ;   et al.
2019-09-19
Fused Pyrimidine Derivatives
App 20190256517 - BARTELS; Bjoern ;   et al.
2019-08-22
Bicyclic Heteroaryl Derivatives
App 20190233427 - BARTELS; Bjoern ;   et al.
2019-08-01
New Trifluoromethylpropanamide Derivatives As Htra1 Inhibitors
App 20190185426 - HORNSPERGER; Benoit ;   et al.
2019-06-20
Difluoroketamide Derivatives As Htra1 Inhibitors
App 20190185427 - Hornsperger; Benoit ;   et al.
2019-06-20
Fused Pyrimidine Derivatives
App 20190177329 - Bartels; Bjoern ;   et al.
2019-06-13
NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRAl INHIBITORS
App 20190152895 - MAERKI; Hans P. ;   et al.
2019-05-23
New Difluoroketamide Derivatives As Htra1 Inhibitors
App 20180371015 - Maerki; Hans P. ;   et al.
2018-12-27
Trifluoromethylpropanamide Derivatives As Htra1 Inhibitors
App 20180371016 - Hornsperger; Benoit ;   et al.
2018-12-27
Trifluoromethylpropanamide derivatives
Grant 9,980,929 - Hornsperger , et al. May 29, 2
2018-05-29
New Difluoroketamide Derivatives
App 20180057526 - HORNSPERGER; Benoit ;   et al.
2018-03-01
New Trifluoromethylpropanamide Derivatives
App 20170348257 - Hornsperger; Benoit ;   et al.
2017-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed